Evidence map›Paper›PMID 26419877›Full record

ArticlemBio2015

Unique Organization of Extracellular Amylases into Amylosomes in the Resistant Starch-Utilizing Human Colonic Firmicutes Bacterium Ruminococcus bromii.

Xiaolei Ze, Yonit Ben David, Jenny A Laverde-Gomez, Bareket Dassa, Paul O Sheridan, Sylvia H Duncan, Petra Louis, Bernard Henrissat, Nathalie Juge, Nicole M Koropatkin and 2 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in mBio, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06292949 (Effect of Resistant Starch on Symptom Improvement and Intestinal Microbiome in Patients With Functional Constipation), which is not on this map. Cited by 86 papers.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed
15.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06292949 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Effect of Resistant Starch on Symptom Improvement and Intestinal Microbiome in Patients With Functional Constipation

TypeinterventionalSponsorHuaping XieRan2023 to 2024Enrolled30ConditionsConstipationArmsResistant starch
3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 175 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Effects ofNutrients · 2020
    Trial
  4. Trial
  5. Gut microbes · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Mucinolysome in gut microbiomes of farm animals and humans.bioRxiv : the preprint server for biology · 2025
    Article
  11. Fat-rich diet promotes microbiome-dependent ATP synthesis in sheep model.Journal of animal science and biotechnology · 2025
    Article
  12. Article
  13. Article
  14. Important roles ofFood science and biotechnology · 2024
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. mSphere · 2024
    Article

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 4 countries.

Xiaolei ZeMicrobiology Group, Rowett Institute of Nutrition and Health, University of Aberdeen, Bucksburn, Aberdeen, Scotland, United Kingdom.
Yonit Ben DavidDepartment of Biological Chemistry, The Weizmann Institute of Science, Rehovot, Israel.
Jenny A Laverde-GomezMicrobiology Group, Rowett Institute of Nutrition and Health, University of Aberdeen, Bucksburn, Aberdeen, Scotland, United Kingdom.
Bareket DassaDepartment of Biological Chemistry, The Weizmann Institute of Science, Rehovot, Israel.
Paul O SheridanMicrobiology Group, Rowett Institute of Nutrition and Health, University of Aberdeen, Bucksburn, Aberdeen, Scotland, United Kingdom.
Sylvia H DuncanMicrobiology Group, Rowett Institute of Nutrition and Health, University of Aberdeen, Bucksburn, Aberdeen, Scotland, United Kingdom.
Petra LouisMicrobiology Group, Rowett Institute of Nutrition and Health, University of Aberdeen, Bucksburn, Aberdeen, Scotland, United Kingdom.
Bernard HenrissatArchitecture et Fonction des Macromolécules Biologiques, UMR6098, Aix-Marseille University, CNRS UMR7257, Marseille, France.
Nathalie JugeInstitute of Food Research, Norwich, United Kingdom.
Nicole M KoropatkinDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Edward A BayerDepartment of Biological Chemistry, The Weizmann Institute of Science, Rehovot, Israel.
Harry J FlintMicrobiology Group, Rowett Institute of Nutrition and Health, University of Aberdeen, Bucksburn, Aberdeen, Scotland, United Kingdom h.flint@abdn.ac.uk.
University of Aberdeen · GBWeizmann Institute of Science · ILCentre National de la Recherche Scientifique · FRQuadram Institute · GBUniversity of Michigan–Ann Arbor · US

Funding

Biotechnology and Biological Sciences Research Council BB/L008602/1Biotechnology and Biological Sciences Research Council BB/L009951/1Wellcome Trust
6 · The paper itself

Abstract

unlabelledRuminococcus bromii is a dominant member of the human gut microbiota that plays a key role in releasing energy from dietary starches that escape digestion by host enzymes via its exceptional activity against particulate "resistant" starches. Genomic analysis of R. bromii shows that it is highly specialized, with 15 of its 21 glycoside hydrolases belonging to one family (GH13). We found that amylase activity in R. bromii is expressed constitutively, with the activity seen during growth with fructose as an energy source being similar to that seen with starch as an energy source. Six GH13 amylases that carry signal peptides were detected by proteomic analysis in R. bromii cultures. Four of these enzymes are among 26 R. bromii proteins predicted to carry dockerin modules, with one, Amy4, also carrying a cohesin module. Since cohesin-dockerin interactions are known to mediate the formation of protein complexes in cellulolytic ruminococci, the binding interactions of four cohesins and 11 dockerins from R. bromii were investigated after overexpressing them as recombinant fusion proteins. Dockerins possessed by the enzymes Amy4 and Amy9 are predicted to bind a cohesin present in protein scaffoldin 2 (Sca2), which resembles the ScaE cell wall-anchoring protein of a cellulolytic relative, R. flavefaciens. Further complexes are predicted between the dockerin-carrying amylases Amy4, Amy9, Amy10, and Amy12 and two other cohesin-carrying proteins, while Amy4 has the ability to autoaggregate, as its dockerin can recognize its own cohesin. This organization of starch-degrading enzymes is unprecedented and provides the first example of cohesin-dockerin interactions being involved in an amylolytic system, which we refer to as an "amylosome." IMPORTANCE: Fermentation of dietary nondigestible carbohydrates by the human colonic microbiota supplies much of the energy that supports microbial growth in the intestine. This activity has important consequences for health via modulation of microbiota composition and the physiological and nutritional effects of microbial metabolites, including the supply of energy to the host from short-chain fatty acids. Recent evidence indicates that certain human colonic bacteria play keystone roles in degrading nondigestible substrates, with the dominant but little-studied species Ruminococcus bromii displaying an exceptional ability to degrade dietary resistant starches (i.e., dietary starches that escape digestion by host enzymes in the upper gastrointestinal tract because of protection provided by other polymers, particle structure, retrogradation, or chemical cross-linking). In this report, we reveal the unique organization of the amylolytic enzyme system of R. bromii that involves cohesin-dockerin interactions between component proteins. While dockerins and cohesins are fundamental to the organization of cellulosomal enzyme systems of cellulolytic ruminococci, their contribution to organization of amylases has not previously been recognized and may help to explain the starch-degrading abilities of R. bromii.

Indexed as

Protein MultimerizationAmino Acid MotifsAmylasesGene Expression ProfilingHumansProteomeRuminococcusStarchAmylasesProteomeStarch

Identifiers

PMID26419877
PMCPMC4611034
OpenAlexW2128144535

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.